A Closer Look At OWC Pharmaceutical Research Corp

OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) has become one of the most talked about and active cannabis names. This comes as the company was trading at just $.0030 at the end of September before turning into a microcap runner and hitting highs of $.2150 on October 24. Now OWCP has pulled back and looks to be consolidating before making its next move higher. For those that haven’t climbed on board yet, here’s a closer look at OWCP.

First up, a little background on the company. OWC Pharmaceutical Research Corp., through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd., conducts medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions including multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines. OWCP is also developing unique delivery systems for the effective delivery and dosage of medical cannabis. The Company’s Research Division is focused on pursuing clinical trials...

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.